Skip to main content

BeiGene opens European headquarters in Basel

| News

BeiGene opens European headquarters in Basel


BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build on European growth out of Basel and its office will initially include 150 employees.

At the opening event: Christof Klöpper, CEO of Basel Area Business & Innovation, talks while John V. Oyler (seated far right), CEO of BeiGene, listens attentively (img: Annelise Michel)

Basel is joining Cambridge, Massachusetts, and Beijing, China, as a location of one of the main regional offices of BeiGene. According to a press release, the biotech’s European organization currently includes more than 270 employees. The Basel office will become a hub for BeiGene’s operations in Europe and initially employ 150 members of staff.

“The skilled talent network in Basel will support our future growth,” said John V. Oyler, Co-Founder, Chairman and CEO at BeiGene. And this is “just the beginning” of growth plans in Europe.

BeiGene is a global, commercial-stage, research-based biotechnology company focused on molecularly-targeted and immuno-oncology cancer therapeutics. Its internal pipeline reportedly consists of 40 novel oral small molecules and monoclonal antibodies for cancer.

“Basel is the biotech hub of continental Europe“

At the opening event of BeiGene Switzerland GmbH, Deborah Strub, Member of the Executive Board and Head of the Cluster & Initiatives Department at the Chamber of Commerce of the two Basel cantons, said “BeiGene’s presence also represents a great opportunity for the Swiss and particularly the Basel economy”. Gerwin Winter, Head of Europe at BeiGene, commented “our new European headquarters in Basel will further strengthen our position and will be a catalyst for changing the lives of European patients.”

Christof Klöpper, CEO of Basel Area Business & Innovation, also welcomes the opening of the new offices. In an article in the Basler Zeitung newspaper he is quoted as saying “Basel is the biotech hub of continental Europe. In recent years we have worked hard to promote this message – to the USA and also China“.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.